Next Article in Journal
Identification of a Highly Potent Neutralizing Nanobody Against Human Adenovirus Type 4
Previous Article in Journal
The Safety and Immunogenicity of a 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT) in 12–23-Month Children: A Double-Blind, Randomized, Phase III Trial in China
 
 
Article

Article Versions Notes

Vaccines 2025, 13(12), 1191; https://doi.org/10.3390/vaccines13121191
Action Date Notes Link
article xml file uploaded 25 November 2025 09:27 CET Original file -
article xml uploaded. 25 November 2025 09:27 CET Update https://www.mdpi.com/2076-393X/13/12/1191/xml
article pdf uploaded. 25 November 2025 09:27 CET Version of Record https://www.mdpi.com/2076-393X/13/12/1191/pdf
article html file updated 25 November 2025 09:29 CET Original file https://www.mdpi.com/2076-393X/13/12/1191/html
Back to TopTop